Our aspirations still disappoint.
Routine thrombectomy during coronary intervention for STEMI is not supported by two large prospective randomized trials. Occasional case-specific clot removal, while appealing, remains an unproven adjunct to primary stenting during STEMI therapy. While early MACE events may be lower, during follow-up, there is a higher risk of stroke in patients who undergo thrombectomy.